These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 27091214

  • 1. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D, Jankovic J.
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [Abstract] [Full Text] [Related]

  • 2. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.
    Vijayakumar D, Jankovic J.
    Drugs; 2016 May; 76(7):759-77. PubMed ID: 27091215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of Tardive Dyskinesia.
    Bashir HH, Jankovic J.
    Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J, Orman J.
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [Abstract] [Full Text] [Related]

  • 11. Dyskinesia: L-dopa-induced and tardive dyskinesia.
    Rascol O, Fabre N.
    Clin Neuropharmacol; 2001 Mar; 24(6):313-23. PubMed ID: 11801806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S.
    Curr Drug Saf; 2016 Mar; 11(1):102-3. PubMed ID: 26391425
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N, Jankovic J.
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Setting the record straight: The nosology of tardive syndromes.
    Truong DD, Frei K.
    Parkinsonism Relat Disord; 2019 Feb; 59():146-150. PubMed ID: 30528171
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL, Piccirilli M, Rizzo PA.
    Riv Neurol; 1984 Feb; 54(3):199-215. PubMed ID: 6147888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.